viernes, 9 de abril de 2010

Alemania: Rechazo a prácticas monopolísticas de la industria farmacéutica...

In plans announced today Rösler is also seeking to drastically cut the price of drugs already on the market by forcing manufacturers to agree them with the German Treasury.

.../...

His plans would also require pharma to demonstrate how new drugs benefit patients and how they build on existing treatments for the same condition.

Más

No hay comentarios: